Information de reference pour ce titreAccession Number: | 00001756-199712220-00012.
|
Author: | Tremblay, Martine 1; Rouillard, Claude 1; Levesque, Daniel 1,2
|
Institution: | (1)Unite de Neuroscience, Centre de Recherche du CHUQ (pavillon CHUL), 2705 Blvd. Laurier, Quebec, QUE, Canada, G1V 4G2; Universite Laval, Faculte de Medecine, Department de Medecine (division pharmacologie), Quebec, QUE, Canada G1K 7P4
|
Title: | |
Source: | Neuroreport. 8(18):3901-3905, December 22, 1997.
|
Abstract: | WE have investigated the effects of a dopamine D3 receptor antisense oligodeoxynucleotide (ODN), on neurotensin and dynorphin mRNA levels in rat nucleus accumbens. Intracerebroventricular injections of ODNs were made into the lateral ventricle (5 and 10 [mu]g h-1, for 5 days). Receptor autoradiography of dopamine D2 and D3 receptor subtypes was performed. Dynorphin and neurotensin mRNA levels were evaluated by in situ hybridization. Dopamine D3 receptor levels were significantly decreased in nucleus accumbens shell (NAS) of rats that received the D3 antisense ODN. Dynorphin and neurotensin mRNA levels were also significantly decreased in the NAS after D3 antisense ODN treatments. Our results show that D3 receptors may regulate neuropeptide gene expression and demonstrate that an antisense strategy could be useful to identify molecular targets under control of specific dopamine receptor subtypes.
(C) Lippincott-Raven Publishers.
|
Author Keywords: | Antisense oligonucleotide; Dopamine D3 receptor; Dynorphin; In situ hybridization; Neuroleptic; Neurotensin; Nucleus accumbens core; Nucleus accumbens shell; Radioreceptor assay; Rat.
|
References: | 1. Sokoloff P, Giros B, Martres M-P et al. Nature 347, 146-151 (1990).
2. Levesque D, Diaz J, Pilon C et al. Proc Natl Acad Sci USA 89, 8155-8159 (1992).
3. Diaz J, Levesque D, Lammers CH et al. Neurosci 65, 731-745 (1995).
4. Merchant KM and Dorsa DM. Proc Natl Acad Sci USA 90, 3447-3451 (1993).
5. Levesque D, Martres M-P, Diaz J et al. Proc Natl Acad Sci USA 92, 1719-1723 (1995).
6. Zahm DS and Brog JS. Neuroscience 50, 751-767 (1992).
7. Diaz J, Levesque D, Griffon N et al. Eur J Neurosci 6, 1384-1387 (1994).
8. Nissbrandt H, Ekman A, Eriksson E et al. Neuroreport 6, 573-576 (1995).
9. Tepper JM, Sun BC, Martin LP et al. J Neurosci 17, 2519-2530 (1997).
10. Weiss B, Zhang S-P and Zhou L-W. Life Sci 60, 433-455 (1997).
11. Levesque D. Biochem Pharmacol 52, 511-518 (1996).
12. Morissette M, Levesque D and Di Paolo T. Mol Pharmacol 42, 480-488 (1992).
13. Kislauslis E, Bullock B, McNeil S et al. J Biol Chem 263, 4963-4968 (1988).
14. Civelli O, Douglass J, Goldstein A et al. Proc Natl Acad Sci USA 82, 4291-4295 (1985).
15. Curran EJ and Watson SJ Jr. J Comp Neurol 361, 57-76 (1995).
16. Gerfen CR, Engber TM, Mahan LC et al. Science 250, 1429-1432 (1990).
17. Fox CA, Mansour A and Watson SJ Jr. Exp Neurol 130, 288-303 (1994).
18. Lynch MR and Ormsby JL. NeuroReport 8, 611-615 (1997).
19. Bordet R, Ridray S, Carboni S et al. Proc Natl Acad Sci USA 94, 3363-3367 (1997).
20. Zhang M, Tarazi F and Creese I. Soc Neurosci Abstr 20, 909 (1994).
21. Accili D, Fishburn CS, Drago J et al. Proc Natl Acad Sci USA 93, 1945-1949 (1996).
22. Whitesell L, Geselowitz D, Chavany C et al. Proc Natl Acad Sci USA 90, 4665-4669 (1993).
23. Zhang S-P, Zhou L-W, Morabito M et al. J Mol Neurosci 7, 13-28 (1996).
24. Qin Z-H, Zhou L-W, Zhang SP et al. Mol Pharmacol 48, 730-737 (1995).
|
Language: | English.
|
Document Type: | Neurochemistry.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0959-4965
|
NLM Journal Code: | a6m, 9100935
|
Annotation(s) | |
|
|